7 recruiting, 3 completed, 3 not yet recruiting, 3 unknown. 4 Phase 3, 3 Phase 2, 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Recruiting 3, Not yet recruiting 1 |
| Phase 2 | 3 | Completed 1, Not yet recruiting 1, Recruiting 1 |
| Not applicable | 1 | Unknown 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow CIDP: new trials by email Literature Review of CIDP trials Research Report on CIDP
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ultrasound-driven Stratification in CIDP Refractory CIDP, Standard-of-care treatment for CIDP - CIDP, Chronic Inflammation | Not yet recruiting | Centre Hospitalier Universitaire de Nice | 30 | 2026-09-01 | 2026-07-22 | |
| A Study to Assess the Correct Dose, Safety and Efficacy of Empasiprubart in Adolescent Participants Aged 12 to Less Than 18 Years With Chronic Inflammatory Demyelinating Polyradiculoneuropathy Empasiprubart IV - Chronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy) | Phase 2 / Phase 3 | Not yet recruiting | argenx | 6 | 2026-09-01 | 2026-06-10 |
| A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP Empasiprubart IV, Placebo IV - Chronic Inflammatory Demyelinating Polyneuropathy, CIDP | Phase 3 | Recruiting | argenx | 160 | 2025-09-16 | 2026-10-27 |
| A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP empasiprubart, IVIg, empasiprubart-placebo - Chronic Inflammatory Demyelinating Polyneuropathy, CIDP | Phase 3 | Recruiting | argenx | 218 | 2025-08-22 | 2026-11-03 |
| Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study Efgartigimod PH20 SC - Chronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDP | Recruiting | argenx | 200 | 2025-08-11 | 2026-11-03 | |
| Vitaccess Real CIDP Registry Chronic Inflammatory Demyelinating Polyneuropathy, CIDP | Not yet recruiting | Vitaccess Ltd | 300 | 2025-07-31 | 2025-06-05 | |
| Rituximab Induced Remission in Patients With Chronic Inflammatory Demyelinating Polyneuropathy Rituximab (Mabthera) - CIDP | Phase 3 | Recruiting | Amsterdam University Medical Center (UMC), Location Academic Medical Center (AMC) | 100 | 2024-10-16 | 2024-12-04 |
| Immunoadsorption Versus Immunoglobulins for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Immunoadsorption, Immunoglobulins - CIDP | Phase 2 | Recruiting | University of Ulm | 20 | 2023-05-01 | 2026-05-01 |
| Validation of Cutaneous Nerve Demyelination in Diagnosis and Treatment of CIDP IVIg - CIDP | Terminated | Vanderbilt University Medical Center | 2 | 2023-02-28 | 2025-06-05 | |
| Electronic Monitoring of Disease Activity in Patients With Chronic Inflammatory Demyelinating Polyneuropathy Smartwatch (Withings Scanwatch) - CIDP | Completed | Heinrich-Heine University, Duesseldorf | 46 | 2023-01-20 | 2024-07-17 | |
| IVIG vs SCIG in CIDP Intravenous immune globulin G, Subcutaneous immune globulin G - CIDP, Immunoglobulin Deficiency | Phase 1 | Recruiting | Rutgers, The State University of New Jersey | 20 | 2022-09-11 | 2025-12-11 |
| Biorepository and Registry for Plasma Exchange Patients Antibody-mediated Rejection, NMO Spectrum Disorder | Recruiting | Charles M Knudson | 200 | 2021-07-28 | 2025-05-20 | |
| Biomarkers in Polyradiculoneuropathies Guillain-Barre Syndrome, CIDP | Unknown | University Hospital, Montpellier | 200 | 2020-01-01 | 2020-01-31 | |
| Changes in Haemostasis After Therapeutic Plasmapheresis With Citrate Anticoagulation Fibrinogen concentrate, Fresh Frozen Plasma - Humoral Rejection, Guillain-Barre Syndrome | Not applicable | Unknown | University Medical Centre Ljubljana | 20 | 2018-10-03 | 2019-01-11 |
| Biomark Study: Predict Intravenous Immunoglobulin Responders in Chronic Inflammatory Demyelinating Polyradiculoneuropathy CIDP treated (IVIG) - CIDP | Completed | Fondation Ophtalmologique Adolphe de Rothschild | 44 | 2014-04-16 | 2023-02-15 | |
| Change of Nerve Conduction Properties in IVIg Dependent Neuropathies Guillain-Barre Syndrome, CIDP | Unknown | University of Cologne | 50 | 2012-10-01 | 2014-12-12 | |
| Lipoic Acid to Treat Chronic Inflammatory Demyelinating Polyneuropathy lipoic acid - CIDP, Chronic Inflammatory Demyelinating Polyneuropathy | Phase 2 | Completed | Oregon Health and Science University | 7 | 2009-02-01 | 2020-08-19 |
| Pre-Approval Access for Efgartigimod PH20 SC in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Efgartigimod PH20 SC - Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), CIDP | Available | argenx | 2026-03-24 |
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (18) · Guillain-Barre Syndrome (3) · Autoimmune Diseases (2) · Immune System Diseases (2) · Nervous System Diseases (2) · Agammaglobulinemia (1) · Anti-Glomerular Basement Membrane Disease (1) · Autoimmune Diseases of the Nervous System (1) · Demyelinating Diseases (1) · Miller Fisher Syndrome (1) · Neurodegenerative Diseases (1) · Neuromuscular Diseases (1) · Neuromyelitis Optica (1) · Obesity (1) · Peripheral Nervous System Diseases (1)
Chronic Disease (18) · Disease Attributes (18) · Pathologic Processes (18) · Pathological Conditions, Signs and Symptoms (18) · Autoimmune Diseases of the Nervous System (17) · Demyelinating Diseases (17) · Neuromuscular Diseases (17) · Peripheral Nervous System Diseases (17) · Polyneuropathies (17) · Polyradiculoneuropathy (17) · Autoimmune Diseases (16) · Immune System Diseases (16) · Nervous System Diseases (16) · Post-Infectious Disorders (3) · Cranial Nerve Diseases (2)
Immunoglobulins, Intravenous (4) · Fibrinogen (1) · Hizentra (1) · Immunoglobulins (1) · Plasmapheresis (1) · Rituximab (1) · Thioctic Acid (1)
argenx (5) · Amsterdam University Medical Center (UMC), Location Academic Medical Center (AMC) (1) · Centre Hospitalier Universitaire de Nice (1) · Charles M Knudson (1) · Fondation Ophtalmologique Adolphe de Rothschild (1) · Heinrich-Heine University, Duesseldorf (1) · Oregon Health and Science University (1) · Rutgers, The State University of New Jersey (1) · University Hospital, Montpellier (1) · University Medical Centre Ljubljana (1) · University of Cologne (1) · University of Ulm (1) · Vanderbilt University Medical Center (1) · Vitaccess Ltd (1)
United States (7) · Germany (5) · France (4) · Netherlands (3) · Argentina (2) · Austria (2) · Brazil (2) · Colombia (2) · Czechia (2) · Estonia (2) · Greece (2) · Hungary (2) · Israel (2) · Italy (2) · Japan (2)
Diana Davis, RN (1) · Guillaume Taieb, MD (1) · Helmar C. Lehmann, PD Dr. med. (1) · Jau-Shin Lou, MD, PhD (1) · Johannes Dorst, Prof (1) · Luigi Brunetti, PhD (1) · Wende Fedder, Rn (1)
2025 (2)